Research Summary
Intravenous Immunoglobulin (IVIg) is a therapeutic preparation consisting of concentrated antibodies derived from pooled human plasma. Administered intravenously, IVIg is used to boost the immune system and treat various medical conditions related to immune deficiencies, autoimmune disorders, and certain neurological diseases. The antibodies in IVIg provide passive immunity by supplying the recipient with a diverse range of antibodies against a variety of pathogens. This therapy is employed in the management of conditions such as primary immunodeficiency disorders, autoimmune diseases like rheumatoid arthritis and lupus, and neurological disorders such as Guillain-Barr?(C) syndrome and chronic inflammatory demyelinating polyneuropathy (CIDP). IVIg is carefully processed to remove potential contaminants and is administered under medical supervision due to the risk of side effects. The therapeutic use of IVIg underscores its role in modulating the immune response and addressing a spectrum of immune-related disorders.
According to DIResearch's in-depth investigation and research, the global Intravenous Immunoglobulin (IVIg) market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Intravenous Immunoglobulin (IVIg) include Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Sichuan Yuanda Shuyang etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Intravenous Immunoglobulin (IVIg). Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Intravenous Immunoglobulin (IVIg) market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Intravenous Immunoglobulin (IVIg) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Intravenous Immunoglobulin (IVIg) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Intravenous Immunoglobulin (IVIg) Include:
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Intravenous Immunoglobulin (IVIg) Product Segment Include:
IVIg Liquid
IVIg Powder
Intravenous Immunoglobulin (IVIg) Product Application Include:
Immunodeficiency
Autoimmune Disease
Acute Infection
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Intravenous Immunoglobulin (IVIg) Industry PESTEL Analysis
Chapter 3: Global Intravenous Immunoglobulin (IVIg) Industry Porter's Five Forces Analysis
Chapter 4: Global Intravenous Immunoglobulin (IVIg) Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Intravenous Immunoglobulin (IVIg) Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Intravenous Immunoglobulin (IVIg) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Intravenous Immunoglobulin (IVIg) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Intravenous Immunoglobulin (IVIg) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Intravenous Immunoglobulin (IVIg) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Intravenous Immunoglobulin (IVIg) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Intravenous Immunoglobulin (IVIg) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Intravenous Immunoglobulin (IVIg) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Intravenous Immunoglobulin (IVIg) Market Overview 1.1 Product Definition and Statistical Scope 1.2 Intravenous Immunoglobulin (IVIg) Product by Type 1.2.1 Global Intravenous Immunoglobulin (IVIg) Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 IVIg Liquid 1.2.3 IVIg Powder 1.3 Intravenous Immunoglobulin (IVIg) Product by Application 1.3.1 Global Intravenous Immunoglobulin (IVIg) Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Immunodeficiency 1.3.3 Autoimmune Disease 1.3.4 Acute Infection 1.4 Global Intravenous Immunoglobulin (IVIg) Market Revenue and Sales Analysis 1.4.1 Global Intravenous Immunoglobulin (IVIg) Market Size Analysis (2019-2030) 1.4.2 Global Intravenous Immunoglobulin (IVIg) Market Sales Analysis (2019-2030) 1.4.3 Global Intravenous Immunoglobulin (IVIg) Market Sales Price Trend Analysis (2019-2030) 1.5 Intravenous Immunoglobulin (IVIg) Market Development Status and Trends 1.5.1 Intravenous Immunoglobulin (IVIg) Industry Development Status Analysis 1.5.2 Intravenous Immunoglobulin (IVIg) Industry Development Trends Analysis 2 Intravenous Immunoglobulin (IVIg) Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Intravenous Immunoglobulin (IVIg) Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Intravenous Immunoglobulin (IVIg) Market Analysis by Regions 4.1 Intravenous Immunoglobulin (IVIg) Overall Market: 2023 VS 2024 VS 2030 4.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Region (2019-2024) 4.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Region (2025-2030) 4.3 Global Intravenous Immunoglobulin (IVIg) Sales and Forecast Analysis (2019-2030) 4.3.1 Global Intravenous Immunoglobulin (IVIg) Sales and Market Share by Region (2019-2024) 4.3.2 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Region (2025-2030) 4.4 Global Intravenous Immunoglobulin (IVIg) Sales Price Trend Analysis (2019-2030) 5 Global Intravenous Immunoglobulin (IVIg) Market Size by Type and Application 5.1 Global Intravenous Immunoglobulin (IVIg) Market Size by Type 5.1.1 Global Intravenous Immunoglobulin (IVIg) Revenue and Forecast Analysis by Type (2019-2030) 5.1.2 Global Intravenous Immunoglobulin (IVIg) Sales and Forecast Analysis by Type (2019-2030) 5.2 Global Intravenous Immunoglobulin (IVIg) Market Size by Application 5.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue and Forecast Analysis by Application (2019-2030) 5.2.2 Global Intravenous Immunoglobulin (IVIg) Sales and Forecast Analysis by Application (2019-2030) 6 North America 6.1 North America Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Intravenous Immunoglobulin (IVIg) Market Size by Type 6.3.1 North America Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2030) 6.3.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Type (2019-2030) 6.4 North America Intravenous Immunoglobulin (IVIg) Market Size by Application 6.4.1 North America Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2030) 6.4.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Application (2019-2030) 6.5 North America Intravenous Immunoglobulin (IVIg) Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Intravenous Immunoglobulin (IVIg) Market Size by Type 7.3.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2030) 7.3.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Type (2019-2030) 7.4 Europe Intravenous Immunoglobulin (IVIg) Market Size by Application 7.4.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2030) 7.4.2 ? Europe Intravenous Immunoglobulin (IVIg) Revenue by Application (2019-2030) 7.5 Europe Intravenous Immunoglobulin (IVIg) Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Intravenous Immunoglobulin (IVIg) Market Size by Type 8.3.1 China Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2030) 8.3.2 China Intravenous Immunoglobulin (IVIg) Revenue by Type (2019-2030) 8.4 China Intravenous Immunoglobulin (IVIg) Market Size by Application 8.4.1 China Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2030) 8.4.2 China Intravenous Immunoglobulin (IVIg) Revenue by Application (2019-2030) 9 APAC (excl. China) 9.1 APAC (excl. China) Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Intravenous Immunoglobulin (IVIg) Market Size by Type 9.3.1 APAC (excl. China) Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2030) 9.3.2 APAC (excl. China) Intravenous Immunoglobulin (IVIg) Revenue by Type (2019-2030) 9.4 APAC (excl. China) Intravenous Immunoglobulin (IVIg) Market Size by Application 9.4.1 APAC (excl. China) Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2030) 9.4.2 APAC (excl. China) Intravenous Immunoglobulin (IVIg) Revenue by Application (2019-2030) 9.5 APAC (excl. China) Intravenous Immunoglobulin (IVIg) Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Intravenous Immunoglobulin (IVIg) Market Size by Type 10.3.1 Latin America Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2030) 10.3.2 Latin America Intravenous Immunoglobulin (IVIg) Revenue by Type (2019-2030) 10.4 Latin America Intravenous Immunoglobulin (IVIg) Market Size by Application 10.4.1 Latin America Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2030) 10.4.2 Latin America Intravenous Immunoglobulin (IVIg) Revenue by Application (2019-2030) 10.5 Latin America Intravenous Immunoglobulin (IVIg) Market Size by Country 10.5.1 Mexico 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Intravenous Immunoglobulin (IVIg) Market Size by Type 11.3.1 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2030) 11.3.2 Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue by Type (2019-2030) 11.4 Middle East & Africa Intravenous Immunoglobulin (IVIg) Market Size by Application 11.4.1 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2030) 11.4.2 Middle East & Africa Intravenous Immunoglobulin (IVIg) Revenue by Application (2019-2030) 11.5 Middle East & Africa Intravenous Immunoglobulin (IVIg) Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Competition by Manufacturers 12.1 Global Intravenous Immunoglobulin (IVIg) Market Sales, Revenue and Price by Key Manufacturers (2020-2024) 12.1.1 Global Intravenous Immunoglobulin (IVIg) Market Sales by Key Manufacturers (2020-2024) 12.1.2 Global Intravenous Immunoglobulin (IVIg) Market Revenue by Key Manufacturers (2020-2024) 12.1.3 Global Intravenous Immunoglobulin (IVIg) Average Sales Price by Manufacturers (2020-2024) 12.2 Intravenous Immunoglobulin (IVIg) Competitive Landscape Analysis and Market Dynamic 12.2.1 Intravenous Immunoglobulin (IVIg) Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Baxter 13.1.1 Baxter Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Baxter Intravenous Immunoglobulin (IVIg) Product Portfolio 13.1.3 Baxter Intravenous Immunoglobulin (IVIg) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.2 Grifols 13.2.1 Grifols Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Grifols Intravenous Immunoglobulin (IVIg) Product Portfolio 13.2.3 Grifols Intravenous Immunoglobulin (IVIg) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.3 CSL 13.3.1 CSL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 CSL Intravenous Immunoglobulin (IVIg) Product Portfolio 13.3.3 CSL Intravenous Immunoglobulin (IVIg) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.4 Octapharma 13.4.1 Octapharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Octapharma Intravenous Immunoglobulin (IVIg) Product Portfolio 13.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.5 Biotest 13.5.1 Biotest Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Biotest Intravenous Immunoglobulin (IVIg) Product Portfolio 13.5.3 Biotest Intravenous Immunoglobulin (IVIg) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.6 Kedrion 13.6.1 Kedrion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Kedrion Intravenous Immunoglobulin (IVIg) Product Portfolio 13.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.7 Hualan Bio 13.7.1 Hualan Bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Portfolio 13.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.8 CNBG 13.8.1 CNBG Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 CNBG Intravenous Immunoglobulin (IVIg) Product Portfolio 13.8.3 CNBG Intravenous Immunoglobulin (IVIg) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.9 Shanghai RAAS 13.9.1 Shanghai RAAS Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Portfolio 13.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.10 CBPO 13.10.1 CBPO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 CBPO Intravenous Immunoglobulin (IVIg) Product Portfolio 13.10.3 CBPO Intravenous Immunoglobulin (IVIg) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.11 LFB Group 13.11.1 LFB Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 LFB Group Intravenous Immunoglobulin (IVIg) Product Portfolio 13.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.12 BPL 13.12.1 BPL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.12.2 BPL Intravenous Immunoglobulin (IVIg) Product Portfolio 13.12.3 BPL Intravenous Immunoglobulin (IVIg) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.13 Sichuan Yuanda Shuyang 13.13.1 Sichuan Yuanda Shuyang Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.13.2 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Portfolio 13.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Intravenous Immunoglobulin (IVIg) Industry Chain Analysis 14.2 Intravenous Immunoglobulin (IVIg) Industry Upstream Supply Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Intravenous Immunoglobulin (IVIg) Typical Downstream Customers 14.4 Intravenous Immunoglobulin (IVIg) Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support